Hassett Barry
HASSETT BARRY, CCO, reported a transaction classified as exercise at BioStem Technologies, Inc. involving 253.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1266.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Nov 01, 2026
- Filing date
- Nov 03, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BSEM price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-445456 Restricted Stock Units
- Transaction date
- Nov 01, 2026 Filed Nov 03, 2026, 09:30 PM · 2d delay
- Shares
- 253 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 1,266 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Commercial Officer
- F1
These options vest according to the following schedule: 33% vested on February 1, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments o…
- F2
These options vest according to the following schedule: 33%% vested on October 13, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments…
- F3
These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installmen…
- F4
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F5
These restricted stock units vest in equal quarterly installments over four years from the grant date (December 9, 2024).
- F6
These restricted stock units vest according to the following schedule: 33% vested on February 1, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly i…
- F7
These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarter…
0 other transactions
0 recent txs